Consequently, there is a critical imperative to conduct further investigations on the role of GK1 through in vivo and human studies, as well as testing with multiple prostate cancer cell lines besides PC-3 cells, to unravel its potential therapeutic implications in targeting cancer cells. The gene discussed is GK; the disease is cancer.